The involvement of type 1a angiotensin II receptors in the regulation of airway inflammation in a murine model of allergic asthma

Clinical and Experimental Allergy

Volumn 37, Issue 11, 2007, Pages 1720-1727

  Ohwada, K ^a   Watanabe, K ^a   Okuyama, K ^a   Ohkawara, Y ^b   Sugaya, T ^c   Takayanagi, M ^a   Ohno, I ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Tanabe Pharmaceutical Co   (Japan)

Author keywords

Airway inflammation; Angiotensin II receptors; AT1a; Bronchial asthma

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; OVALBUMIN;

AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; EOSINOPHIL; HELPER CELL; HISTOCHEMISTRY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; KNOCKOUT MOUSE; LUNG; LUNG LAVAGE; MOUSE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TH1 CELL; WILD TYPE;

ANIMALS; ASTHMA; BRONCHITIS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN E; LIPOPOLYSACCHARIDES; LUNG; LYMPHOCYTES; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCUS; NEUTROPHILS; OVALBUMIN; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 35348955856     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02815.x     Document Type: Article

References (24)

1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000 161 : 1720 45.
2. Riffo-vasquez Y, Spina D. Role of cytokines and chemokines in bronchial hyper-responsiveness and airway inflammation. Pharmacol Ther 2002 94 : 185 211.
3. Kay AB. The role of T lymphocytes in asthma. Chem Immunol Allergy 2006 91 : 59 75.
4. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger TH. The angiotensin II receptors. Pharmacol Rev 2000 52 : 415 72.
5. Millar EA, Angus RM, Hulks G, Morton JJ, Connell JM, Thomson NC. Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function. Thorax 1994 49 : 492 5.
6. Ramsay SG, Dagg KD, McKay IC, Lipworth BJ, McSharry C, Thomson NC. Investigations on the renin-angiotensin system in acute severe asthma. Eur Respir J 1997 10 : 2766 71.
7. Millar EA, Nally JE, Thomson NC. Angiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivo. Eur Respir J 1995 8 : 1838 41.
8. Myou S, Fujimura M, Kamio Y et al. Effect of losartan, a type 1 angiotensin II receptor antagonist, on bronchial hyperresponsiveness to methacholine in patients with bronchial asthma. Am J Respir Crit Care Med 2000 162 : 40 4.
9. Myou S, Fujimura M, Kamio Y et al. Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma. Br J Clin Pharmacol 2002 54 : 622 6.
10. Dicpinigaitis PV, Dobkin JB. Effect of angiotensin II receptor blockade on bronchial responsiveness in asthmatic subjects. J Allergy Clin Immunol 1998 102 : 521 2.
11. Tanaka H, Teramoto S, Oashi K et al. Effects of candesartan on cough and bronchial hyperresponsiveness in mildly to moderately hypertensive patients with symptomatic asthma. Circulation 2001 104 : 281 5.
12. Myou S, Fujimura M, Kurashima K, Tachibana H, Watanabe K, Hirose T. Type 1 angiotensin II receptor antagonism reduces antigen-induced airway reactions. Am J Respir Crit Care Med 2000 162 : 45 9.
13. Roisman GL, Danel CJ, Lacronique JG, Alhenc-Gelas F, Dusser DJ. Decreased expression of angiotensin-converting enzyme in the airway epithelium of asthmatic subjects is associated with eosinophil inflammation. J Allergy Clin Immunol 1999 104 : 402 10.
14. Weidanz JA, Jacobson LM, Muehrer RJ et al. ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro. Kidney Int 2005 67 : 2134 42.
15. Shao J, Nangaku M, Miyata T et al. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003 42 : 31 8.
16. Sagawa K, Nagatani K, Komagata Y, Yamamoto K. Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice. Arthritis Rheum 2005 52 : 1920 8.
17. Hisada Y, Sugaya T, Yamanouchi M et al. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 1999 103 : 627 35.
18. Kumagai K, Ohno I, Okada S et al. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol 1999 162 : 4212 9.
19. Ohno I, Ohtani H, Nitta Y et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997 16 : 212 9.
20. Scherf W, Burdach S, Hansen G. Reduced expression of transforming growth factor β1 exacerbates pathology in an experimental asthma model. Eur J Immunol 2005 35 : 198 206.
21. Mazzolai L, Duchosal MA, Korber M et al. Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice. Hypertension 2004 44 : 277 82.
22. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002 2 : 933 44.
23. Imai Y, Kuba K, Rao S et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005 436 : 112 6.
24. Dart RA, Gollub S, Lazar J, Nair C, Schroeder D, Woolf SH. Treatment of systemic hypertension in patients with pulmonary disease: COPD and asthma. Chest 2003 123 : 222 43.